Litcius/Paper detail

TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial

Man‐Fung Yuen, R. Balabanska, Emmanuelle Cottreel, Ethan Chen, Dan Duan, Qiudi Jiang, Avinash S. Patil, Miriam Triyatni, Ruchi Upmanyu, Zhu Yonghong, Filippo Canducci, Edward Gane

2022The Lancet Infectious Diseases42 citationsDOI

Topics & Concepts

MedicinePlaceboTolerabilityInternal medicineAgonistGastroenterologyAdverse effectReceptorPathologyAlternative medicineHepatitis B Virus StudiesImmune Response and InflammationHepatitis C virus research